Opens in a new tab or window Follicular lymphoma is ... indolent slow-growing follicular lymphoma into a more aggressive lymphoma -- diffuse large B-cell lymphoma." Thus, "it is important that ...

The following is a summary of “Identification of molecular clusters and a risk prognosis model for diffuse large B-cell ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer ... About one in five people with lymphoma have follicular lymphoma. This is a slow-growing form that mainly affects older adults.

It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. It is positive for the B-cell markers CD10, CD19 ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate of watch-and-wait patients was not inferior to that o ...

Kymriah was cleared by the FDA for the follicular lymphoma use last year as well, a little after Yescarta, adding to its earlier approvals for diffuse large B-cell lymphoma (DLBCL) and acute ...

In a recent Phase II study, 46 relapsed patients with indolent or aggressive B-cell NHL (the majority with follicular lymphoma) received oblimersen combined with rituximab. [75] Responses were ...

Taking a patient's immune cells and targeting their cancer with them, which is called CAR T cell therapy, is showing promise ...

Wojciech Jurczak, MD, PhD, discusses the future of B-cell lymphoma therapy ... In lymphomas where BTK inhibition is less effective, such as follicular lymphoma, zanubrutinib combined with rituximab ...